Navigation Links
Medizone International, Inc. Announces Establishment of Canadian Foundation for Global Health
Date:10/30/2008

SAN FRANCISCO, Oct. 30 /PRNewswire-FirstCall/ -- Medizone International, Inc. (Pink Sheets: MZEI) is pleased to announce the formal establishment of a not-for-profit affiliate, the Canadian Foundation for Global Health (CFGH). CFGH was founded under Canadian Federal Law as a not-for-profit Canadian Corporation headquartered in Ottawa, Ontario, Canada. Under the leadership of Dr. Michael E. Shannon, a founding Director and the foundations' newly appointed President, it is anticipated that the foundation will attract a broad spectrum of the most highly qualified scientists, infectious disease specialists and other medical health professionals from diverse fields of interest to serve on its Board of Directors, Science Advisory Board or as Principal Investigators.

Medizone's Board of Directors have adopted a business philosophy of "creating a corporate paradigm in which the corporation's profit follows its' social contribution." The establishment of this foundation fits into that paradigm not only by being positioned to attract the highest quality professionals possible to our research projects, but it is envisioned that as Medizone's products and treatments become ready for market, the foundation may play a vital role as a distribution source for developing countries with varying price breaks depending on the county's needs and the availability of international assistance; we intend to make effort through both the for-profit and the non-profit to make affordable medical solutions as widely available as possible for the people of the planet.

Medizone International, Inc., is a research and development stage company engaged in the development of novel technologies and protocols for O3 based bio-oxidative treatment of diseases caused by lipid enveloped viruses, including Acquired Immune Deficiency Syndrome (AIDS), Hepatitis B & C, and Herpes, the decontamination of blood, blood products and veterinarian serum products, and the treatment of external pathogenic conditions. It is currently developing technology to sterilize hospital surgical suites, emergency rooms and intensive care units.

This Press Release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.

Web site: http://www.medizoneint.com

Investor Relations: 800-953-3350


'/>"/>
SOURCE Medizone International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Medizone International, Inc. Appoints Dr. Michael E. Shannon to Its Board of Directors
2. Sangui Biotech International, Inc., Reports Sales Decrease, Continued Losses
3. Cryo-Cell International, Inc. Reports Third Quarter 2008 Results
4. China Yingxia International, Inc. Announces $2 Million Share Repurchase Program
5. BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board
6. China Yingxia International, Inc. Appoints New Vice President of Finance
7. Chindex International, Inc. Announces Appearances at Upcoming Investor Conferences
8. Sangui BioTech International, Inc. Files Remaining Reports
9. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
10. BioEnergy International, LLC Acquires Assets of OmniGene Bioproducts, Inc.
11. Cryo-Cell International, Inc. Reports Second Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry Network for ... Design Lab . Located in Pasadena, Calif., the Design Lab’s mission is to ... are designed, built and brought to market. , The Design Lab is Supplyframe’s ...
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
(Date:6/23/2016)... -- On Wednesday, June 22, 2016, the NASDAQ ... Dow Jones Industrial Average edged 0.27% lower to finish at ... Stock-Callers.com has initiated coverage on the following equities: Infinity Pharmaceuticals ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ... Learn more about these stocks by accessing their free trade ...
Breaking Biology Technology:
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/14/2016)... April 14, 2016 BioCatch ... Detection, today announced the appointment of Eyal Goldwerger ... role. Goldwerger,s leadership appointment comes at a ... of the deployment of its platform at several of ... technology, which discerns unique cognitive and physiological factors, is ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):